Tu, T., Chen, M., Li, M., Liu, L., Chen, Z., Lin, J., . . . Zhuang, X. Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn’s disease. SAGE Publishing.
Chicago Style (17th ed.) CitationTu, Tong, et al. Early Intervention with Ustekinumab Is Associated with Higher Rates of Clinical and Endoscopic Remission in Patients with Crohn’s Disease. SAGE Publishing.
MLA (9th ed.) CitationTu, Tong, et al. Early Intervention with Ustekinumab Is Associated with Higher Rates of Clinical and Endoscopic Remission in Patients with Crohn’s Disease. SAGE Publishing.
Warning: These citations may not always be 100% accurate.